The Semaglutide Surge: Pharma’s New Gold Mine
The Masterful and Affordable Revolution of Metabolic Health in India For the past three years, names like Ozempic and Wegovy have dominated global headlines, but their high cost and chronic supply shortages kept them out of reach for millions. As of today, early 2026, that “exclusivity wall” is finally crumbling. Indian pharmaceutical giants are not … Read more